683 Capital Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-41,629
Closed -$149K 355
2022
Q1
$149K Hold
41,629
0.01% 279
2021
Q4
$358K Buy
+41,629
New +$265K 0.01% 247

Other funds holding LHDX

683 Capital Management's LHDX Position: Q2 2022 in Review

683 Capital Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2022, closing a stake of 41,629 shares — an estimated $149K sold.

683 Capital Management first reported a position in LHDX in Q4 2021 and held it in 2 quarters. The position peaked at $358K in Q4 2021. 38 funds tracked by Wall St. Rank hold LHDX as of Q2 2022.

  • 683 Capital Management reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • 683 Capital Management sold 41,629 Lucira Health, Inc. Common Stock shares in Q2 2022, an estimated $149K.
  • 683 Capital Management first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • 683 Capital Management's Lucira Health, Inc. Common Stock position peaked at $358K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2022.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.